SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-011951
Filing Date
2024-02-08
Accepted
2024-02-08 08:05:16
Documents
15
Period of Report
2024-02-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm245513d1_8k.htm   iXBRL 8-K 26982
2 EXHIBIT 99.1 tm245513d1_ex99-1.htm EX-99.1 75821
  Complete submission text file 0001104659-24-011951.txt   288067

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA repl-20240208.xsd EX-101.SCH 3018
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE repl-20240208_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE repl-20240208_pre.xml EX-101.PRE 22361
16 EXTRACTED XBRL INSTANCE DOCUMENT tm245513d1_8k_htm.xml XML 3724
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

IRS No.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38596 | Film No.: 24606927
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)